Mild Cognitive Impairment Modelling of Disease due to Inflammation: A Bottom-Up & Longitudinal Overview of Infection Exposure Induced Inflammation in Older Adults
Abstract
Introduction: Global population aging has increased the burden of age-related cognitive disorders, with mild cognitive impairment representing a critical transitional stage between normal aging and dementia. Although conventional models of Mild Cognitive Impairment pathogenesis emphasize neurodegenerative processes such as amyloid-β and tau pathology, accumulating evidence highlights the central role of systemic and neuroinflammation in early cognitive decline. This review conceptualizes Mild Cognitive Impairment as an inflammation-mediated condition using a bottom-up and longitudinal framework, with particular emphasis on infection exposure, especially SARS-CoV-2 as a trigger of sustained inflammatory responses in older adults. Methods: A structured review of PubMed and ScienceDirect (2021–2026) synthesized observational studies in adults ≥60 linking inflammatory biomarkers to Mild Cognitive Impairment outcomes. Results: Elevated systemic inflammatory markers, particularly C-reactive protein, interleukin-6, tumor necrosis factor-α, D-dimer, and lactate dehydrogenase, were consistently associated with impairments in executive function, processing speed, and global cognition. Longitudinal findings revealed heterogeneous cognitive trajectories, with partial recovery in some domains but persistent deficits lasting up to 42 months post-infection. Neuroimaging and biomarker evidence supported inflammation-mediated mechanisms, including microstructural brain alterations and neuroaxonal injury indicated by increased plasma neurofilament light chain, in the absence of direct viral neuroinvasion. Psychological stress and mental health symptoms further interacted with immune dysregulation, amplifying cognitive vulnerability. Conclusions: Overall, findings support a multifactorial, inflammation-driven model of Mild Cognitive Impairment, where infection-induced immune activation interacts with aging vulnerability, neurobiological injury, and psychosocial factors, highlighting the value of longitudinal inflammatory frameworks for earlier risk stratification and development of targeted preventive and disease-modifying interventions.

